Company intelligence / Profile preview

Scimplify

Bengaluru, Karnataka, Indiascimplify.com ↗

Ownership: Private
Employees: ~36
Development stage: Other

Overview

Scimplify does not develop its own clinical assets but provides end-to-end R&D, custom synthesis, process development, manufacturing scale-up, regulatory support and supply chain solutions to pharma/life science companies. It enables rapid development of APIs/intermediates with high quality standards. No direct clinical results since it’s not an innovator biotech/pharma.

Modalities: Small molecule (APIs and intermediates)Peptides (as per expertise in nucleosides and peptides)Custom synthesis/chemical intermediates
Industry: Contract Manufacturing Organization

Partnerships

Partners with >150 chemical manufacturers globally through its Atoms platform; no specific major pharma/biotech partnerships named publicly.

Beyond the preview

Go deeper on Scimplify.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Scimplify.

Explore the full profile